12.5907.49% ( -1.020 )
Closed: Nov 13, 16:00:00 (EDT)Shareholders
All Shareholders
Shareholder Type
- VC/PE firms31.01%
- Public and others24.99%
- Institutions20.21%
- Public companies9.90%
- Others13.89%
Major Shareholders
| Shareholder | |||||
|---|---|---|---|---|---|
Arch Venture Partners, L.P. | 12.91% | 3.75M | -- | +3.75M | |
OrbiMed Advisors LLC | 12.34% | 3.59M | -- | +3.59M | |
FMR LLC | 11.18% | 3.25M | -- | +3.25M | |
Gilead Sciences, Inc. | 9.90% | 2.88M | -- | +2.88M | |
Qatar Investment Authority | 6.65% | 1.93M | -- | +1.93M | |
Frazier Life Sciences Management, LP | 5.76% | 1.67M | -- | +1.67M | |
Q Healthcare Holding LLC | 4.59% | 1.33M | -- | +1.33M | |
Abu Dhabi Investment Authority | 4.46% | 1.30M | -- | +1.30M | |
Medical Excellence Capital, LLC | 3.71% | 1.08M | -- | +1.08M | |
Damien McDevittPresident, CEO & Director | 1.93% | 561.65K | -- | +561.65K | |
Axon Ventures | 0.86% | 250.42K | -- | +250.42K | |
Faheem HasnainExecutive Chairman | 0.22% | 63.01K | -- | +63.01K | |
Andrew SpaventaIndependent Director | 0.20% | 57.66K | -- | +57.66K | |
Thomas DanielIndependent Director | 0.12% | 35.14K | -- | +35.14K | |
Jon Spaventa | 0.07% | 20.24K | -- | +20.24K | |
Sharon Spaventa | 0.07% | 20.24K | -- | +20.24K | |
AG Artemis Holdings, L.P. | 0.05% | 13.33K | -- | +13.33K | |
Dalen MeeterChief Financial Officer | 0.00% | 0.00 | -- | +0 | |
Peter ThompsonIndependent Director | 0.00% | 0.00 | -- | +0 | |
Kim RaineriChief Technology Officer | 0.00% | 0.00 | -- | +0 |
